Dogwood Therapeutics, Inc. Notes Payable
Dogwood Therapeutics, Inc. (DWTX) had Notes Payable of $0 as of 2020-12-31, per its 10-K filed 2022-03-18.
Discontinued › Balance Sheet
us-gaap:NotesPayable · last filed 2022-03-18
- 2020-12-31: Notes Payable $0.00.
- 2020-09-30: Notes Payable $4.20M.
- 2020-06-30: Notes Payable $6.71M.
- 2020-03-31: Notes Payable $4.84M.
| Period end | Notes Payable |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2020-09-30 | $4.20M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $6.71M 10-Q · filed 2021-08-13 |
| 2020-03-31 | $4.84M 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |